Pediatric Metastatic Hepatoblastoma With an ARID1A Mutation and Rhabdoid Cells.

Autor: Alturkustani, Murad, Gallant, Rachel, Raca, Gordana, Ranganathan, Sarangarajan, Mahabir, Roshan, Biegel, Jaclyn A., Mascarenhas, Leo, Moke, Diana, Szymanski, Linda J.
Předmět:
Zdroj: International Journal of Surgical Pathology; May2022, Vol. 30 Issue 3, p307-312, 6p
Abstrakt: The small cell undifferentiated component of hepatoblastoma is an uncommon histologic component and is distinguished from small cell undifferentiated like pattern (originally called hepatoblastoma and now recognized to be malignant rhabdoid tumor) by the bi-allelic SMARCB1 mutations or copy number alterations in the latter. AT-rich interactive domain-containing protein 1A (ARID1A) is a part of the ATP-dependent switch/sucrose non-fermentable complex assembly, but mutations have not been reported as drivers of malignant rhabdoid tumor. ARID1A mutations in hepatocellular carcinoma are associated with poor prognosis but its significance in hepatoblastoma is unknown. We report a unique case of hepatoblastoma in a 19-month-old female with an unusual/atypical small cell undifferentiated component with ARID1A and beta-catenin mutations. It had an aggressive clinical course despite treatment, with metastases to the left psoas muscle, perihepatic and paratracheal lymph nodes, spinal cord, and leptomeninges. Leptomeningeal metastases resulted in diffuse cerebral edema and death. The initial diagnostic biopsy did not reveal rhabdoid cells while all metastatic foci showed cells with rhabdoid morphology in the autopsy specimens. Although this rhabdoid component resembled malignant rhabdoid tumor morphologically, molecular analyses failed to show mutations or deletions of SMARCB1. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index